Pegylated interferon 2a and ruxolitinib induce a high rate of oral complications among patients with myeloproliferative neoplasms-Reference-Cited by-同舟云学术

Pegylated interferon 2a and ruxolitinib induce a high rate of oral complications among patients with myeloproliferative neoplasms

Published:2020-06 Issue:1 Volume:1 Page:350-352
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Orliaguet Marie¹,Boisramé Sylvie¹,Eveillard Jean‐Richard²,Pan‐Petesch Brigitte²³,Couturier Marie‐Anne²,Rebière Vincent²,Guillerm Gaelle²,Le Bousse‐Kerdiles Marie‐Caroline⁴⁵,Misery Laurent⁶,Lippert Eric⁵⁷⁸^ORCID,Ianotto Jean‐Christophe²³⁵^ORCID

Affiliation:

1. Département de Chirurgie OraleCHRU de Brest Brest France

2. Service d'Hématologie Clinique, Institut de Cancéro‐HématologieCHRU de Brest Brest France

3. EA3878, Groupe d'Etude des Thromboses de Bretagne Occidentale, GETBOCHRU de Brest Brest France

4. UMR‐S‐MD 1197, Institut André LwoffUniversité Paris XI Villejuif France

5. France Intergroupe des Néoplasies Myéloprolifératives (FIM)

6. Service de DermatologieCHRU de Brest Brest France

7. Laboratoire d'HématologieCHRU de Brest Brest France

8. INSERM, UMR 1078Université de Brest Brest France

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.15

Reference10 articles.

1. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management

2. Primary myélofibrosis: 2019 update on diagnosis, risk‐stratification and management;Tefferi A;Am J Hematol,2019

3. Symptomatic mucocutaneous toxicity of hydroxyurea in Philadelphia chromosome-negative myeloproliferative neoplasms

4. Staphylococcus aureus bacteremia in patients receiving pegylated interferon-alpha and ribavirin for chronic hepatitis C virus infection

5. Incidence of Neutropenia and Infections During Combination Treatment of Chronic Hepatitis C with Pegylated Interferon Alfa-2a or Alfa-2b Plus Ribavirin